Cantitate/Preț
Produs

Translational ADMET for Drug Therapy – Principles, Methods, and Pharmaceutical Applications

Autor SB Yanni
en Limba Engleză Hardback – 6 oct 2015
Serving as a practical handbook about ADMET for drug therapy, this book presents effective technologies, methods, applications, data interpretation, and decision-making tactics for pharmaceutical and preclinical scientists. Chapters cover case studies and in vivo, in vitro, and computational tools for drug discovery and development, with new translational approaches to clinical drug investigations in various human populations. * Illustrates ADME properties, from bedside to bench and bench to bedside, for the design of safe and effective medicine in human populations * Provides examples that demonstrate the integration of in vitro, in vivo, and in silico data to address human PKPD and TKTD and help determine the proper therapeutic dosage * Presents successful tools for evaluating drugs and covers current translational ADMET with regulatory guidelines * Offers a hands-on manual for researchers and scientists to design and execute in vitro, in silico, preclinical, and clinical studies * Includes discussion of IND / NDA filing and drug labeling to support drug registration and approval
Citește tot Restrânge

Preț: 86662 lei

Preț vechi: 91223 lei
-5% Nou

Puncte Express: 1300

Preț estimativ în valută:
16588 17393$ 13706£

Carte tipărită la comandă

Livrare economică 29 ianuarie-12 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781118838273
ISBN-10: 1118838270
Pagini: 352
Dimensiuni: 164 x 235 x 28 mm
Greutate: 0.68 kg
Editura: Wiley
Locul publicării:Hoboken, United States

Public țintă

Medicinal chemists, DMPK scientists, pharmacologists, pharmaceutical scientists
Drug discovery scientists: biochemists, formulators, toxicologists, pre–clinical scientists, preclinical and clinical safety scientists
Companies providing services in ADMET and drug development, pharmaceutical companies
R&D managers and regulatory professionals

Cuprins


Notă biografică

Souzan B. Yanni, PhD, is Founder and President of DMPK Consultants, Inc., which leads ADME/PK in support of preclinical and clinical investigations for of pharmaceutical and biotech companies. She has over 20 years of hands-on leadership experience in planning, executing, and overseeing drug discovery and early development for therapeutic programs with national and international pharmaceutical companies, biotech groups, and CROs. Dr. Yanni possesses a PhD in Pharmaceutical Sciences, MS in Biochemistry, and BS in Chemistry. She is the author of several peer-reviewed articles, review articles, and book chapters on ADMET/PK as well as an external reviewer / editor for other journals.

Descriere

Serving as a practical handbook about ADMET for drug therapy, this book presents effective technologies, methods, applications, data interpretation, and decision-making tactics for pharmaceutical and preclinical scientists.